Palatin Technologies PTN
NASDAQ PTN
$12.02 -0.31 (-2.51%)
At close: Sep 10, 2026 · 4:00 PM EDT

Palatin Technologies (PTN) EBITDA (2010 - 2026)

Palatin Technologies' (PTN) quarterly EBITDA came in at -$1.6 million in Q1 2026, up 67.15% on a YoY basis from -$945837.6 in Q1 2025, and up 78.43% quarter-over-quarter from -$7.3 million in Q4 2025.

Analysis

Palatin Technologies (PTN) EBITDA (2010 - 2026) Analysis & Trends

Palatin Technologies (PTN) has reported EBITDA for 17 consecutive years, with -$1.6 million the latest figure, recorded in Q1 2026.

  • For the quarter ending Q1 2026, EBITDA rose 67.15% year-over-year to -$1.6 million; the trailing twelve-month figure through Mar 2026 stood at -$6.5 million (up 72.3% YoY), and the FY2025 full-year result was -$17.5 million, up 22.39% from the prior year.
  • EBITDA grew to -$1.6 million in Q1 2026 per PTN's latest filing, from -$7.3 million in the prior quarter.
  • Across five years, EBITDA topped out at $4.7 million in Q3 2025 and bottomed at -$13.1 million in Q2 2022.
  • Historically, EBITDA has averaged -$5.7 million across 5 years, with a median of -$7.3 million in 2023.
  • The sharpest annual moves came in 2024 and 2025: EBITDA plunged 322.59% in 2024, then jumped 160.03% in 2025.
  • Over 5 years, EBITDA stood at -$5.6 million in 2022, then soared by 121.0% to $1.2 million in 2023, then slumped by 322.59% to -$2.6 million in 2024, then slumped by 180.65% to -$7.3 million in 2025, then soared by 78.43% to -$1.6 million in 2026.
  • According to Business Quant data, EBITDA over the past three periods registered -$1.6 million, -$7.3 million, and $4.7 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBITDA (Qtr)
1 Amgen 206.44 Bn 192.45 Bn 7.24 Bn 3.51 Bn
2 Gilead Sciences 179.97 Bn 176.79 Bn 6.22 Bn -10.39 Bn
3 Vertex Pharmaceuticals 130.57 Bn 122.72 Bn 2.84 Bn 1.25 Bn
4 Regeneron Pharmaceuticals 81.63 Bn 73.63 Bn 3.93 Bn 1.29 Bn
5 Argenx Se 60.34 Bn 55.16 Bn 1.37 Bn 493.00 Mn
6 Moderna 54.37 Bn 49.23 Bn 52.00 Mn -815.00 Mn
7 Alnylam Pharmaceuticals 33.07 Bn 29.76 Bn 992.69 Mn 231.44 Mn
8 Biogen 31.84 Bn 30.55 Bn 1.96 Bn -644.50 Mn
9 Roivant Sciences 29.49 Bn 29.49 Bn 1.16 Mn -365.99 Mn
10 Palatin Technologies 46.98 Mn 46.98 Mn - -1.58 Mn
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 -1.58 Mn
Dec 31, 2025 -7.33 Mn
Sep 30, 2025 4.66 Mn
Jun 30, 2025 -2.27 Mn
Mar 31, 2025 -4.81 Mn
Dec 31, 2024 -2.61 Mn
Sep 30, 2024 -7.76 Mn
Jun 30, 2024 -8.34 Mn
Mar 31, 2024 -9.22 Mn
Dec 31, 2023 1.17 Mn
Sep 30, 2023 -6.11 Mn
Jun 30, 2023 -10.82 Mn
Mar 31, 2023 -7.30 Mn
Dec 31, 2022 -5.59 Mn
Sep 30, 2022 -8.75 Mn
Jun 30, 2022 -13.10 Mn
Mar 31, 2022 -7.82 Mn
Dec 31, 2021 -8.45 Mn
Sep 30, 2021 -7.22 Mn
Jun 30, 2021 -13.70 Mn